Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor Mavoglurant

Recruiting

Early Phase 1

MavoglurantFunctional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor Mavoglurant

Sponsor:

Yale University

Code:

NCT05203965

Conditions

Familial Alcoholism Vulnerability

Eligibility Criteria

Sex: All

Age: 18 - 45

Healthy Volunteers: Accepted

Interventions

Mavoglurant (AFQ056)

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-24. This information was provided to ClinicalTrials.gov by Yale University on 2025-10-09.